David A. Ricks is Chairman, President & Chief Executive Officer at Eli Lilly & Co. since 2017. He is Chairman & Chief Executive Officer at Eli Lilly & Co. Ltd. and Eli Lilly Italia SpA. He serves as Chairman-Governors Board at James Whitcomb Riley Children's Foundation. He is an Independent Director at Adobe, Inc. since 2018. He is Director at Pharmaceutical Research & Manufacturers of America since 2022. He is Director at The Central Indiana Corporate Partnership. He is a Member of The Business Roundtable and The Business Council. Former roles include Director at European Federation of Pharmaceutical Industries & Assns, Director at Elanco Animal Health, Inc. from 2018 to 2019, Principal at HP, Inc., Principal at International Business Machines Corp., President at International Federation of Pharmaceutical Manufacturers, President at Lilly USA LLC from 2009 to 2012, President & General Manager at Lilly Industries Shanghai Ltd. in 2009, and General Manager at Eli Lilly Canada, Inc. from 2005 to 2008. Education includes an MBA from Indiana University in 1996 and an undergraduate degree from Purdue University in 1990.
Jon Erik Fyrwald
Mr. Jon E. Fyrwald is a Chief Executive Officer & Director at International Flavors & Fragrances, Inc., a Chairman at ADAMA Ltd., a Chief Executive Officer & Director at Syngenta International AG, an Independent Director at Eli Lilly & Co., a Chairman & Chief Executive Officer at Syngenta Foundation For Sustainable Agriculture, a Chief Executive Officer at Syngenta Crop Protection – Solu??es Para A Agricultura, Ltda. and a Chief Executive Officer & Director at Syngenta Bangladesh Ltd. He is on the Board of Directors at International Flavors & Fragrances, Inc., ADAMA Agricultural Solutions Ltd., Syngenta International AG, Syngenta Crop Protection AG, Syngenta Group Co., Ltd., Eli Lilly & Co., Syngenta Bangladesh Ltd., Biotechnology Innovation Organization, CropLife International, Society of Chemical Industry, Syngenta AG, The Chicago Public Education Fund and The Field Museum of Natural History. Mr. Fyrwald was previously employed as a Chairman by Sinofert Holdings Ltd., an Independent Director by Bunge Ltd., a Chairman-Management & Member-Management Director by Syngenta AG, a President & Chief Executive Officer by Univar NV, a President, Chief Executive Officer & Director by Univar, Inc., a President & Chief Executive Officer by Univar Ltd., a President by Ecolab, Inc., a Chairman, President & Chief Executive Officer by Nalco Co., a Chairman, President & Chief Executive Officer by Nalco Holding Co., a Group VP-Agriculture & Nutrition Division by E.I. du Pont de Nemours & Co., and a Chief Executive Officer by Univar Solutions USA, Inc. (Illinois). He also served on the board at 8th Continent LLC, American Chemistry Council, Inc., Amsted Industries, Inc., Edmundson Art Foundation, Inc., Swiss-American Chamber of Commerce, United Way of Central Iowa and World Food Programme. He received his undergraduate degree from the University of Delaware.
Ralph Alvarez
Ralph Alvarez is currently Chairman at First Watch Restaurant Group, Inc. since 2019. Independent Director at Eli Lilly & Co. since 2009. Independent Director at Lowe's Companies, Inc. since 2010. Lead Independent Director at Traeger, Inc. since 2021. Member of the Presidents Council at the University of Miami School of Business. Formerly Executive Chairman at Skylark Co. Ltd. from 2013 to 2018. Chairman at Skylark Holdings Co., Ltd. from 2013 to 2018. Director at KeyCorp from 2005 to 2009. President, Chief Operating Officer & Director at McDonald's Corp. from 2006 to 2009. Regional Director at Chipotle Mexican Grill, Inc. from 1999 to 2000. Lead Independent Director at Dunkin' Brands Group, Inc. from 2012 to 2020. Director at Dunkin' Brands, Inc. from 2013 to 2020. Independent Director at Anywhere Real Estate, Inc. from 2013 to 2018. Vice President-Florida Division at Wendy's International LLC from 1990 to 1994. Budget Analyst at Burger King Corp. from 1977 to 1989. President at McDonald’s North America from 2005 to 2006. President at McDonald's Mexico in 2005. COO & President-Central Division at McDonald's USA LLC from 2006 to 2009. Education includes an undergraduate degree from the University of Miami, conferred in 1976.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Katherine Baicker
Katherine Baicker is currently an Independent Director at Eli Lilly & Co. since 2011, a Trustee at Mayo Clinic since 2019, a Member of the Council on Foreign Relations, Inc., American Academy of Arts & Sciences, National Academy of Medicine (United States), and National Academy of Social Insurance. Dr. Baicker is a Research Associate at the National Bureau of Economic Research, Inc., a Trustee at The Chicago Council on Global Affairs and National Opinion Research Center, and serves as Dean & Professor at The University of Chicago Harris School of Public Policy and Dean at Harris School of Public Policy Studies since 2017. Former positions include Independent Director at HMS Holdings Corp. from 2019 to 2021, Associate Professor & Assistant Professor at Dartmouth College from 1998 to 2005, Member of the Council of Economic Advisers from 2005 to 2007, and Professor-Health Economics at Harvard T.H. Chan School of Public Health from 2007 to 2017. Other former roles include Chairman-Social Sciences & Population Study at National Institutes of Health, Vice Chairman at AcademyHealth, Chairman at The Group Insurance Commission, Trustee at The Urban Institute, and Member-Editorial Board at Health Affairs. Education includes a doctorate from Harvard University conferred in 1998 and an undergraduate degree from Yale University conferred in 1993.
David A. Ricks
David A. Ricks is Chairman, President & Chief Executive Officer at Eli Lilly & Co. since 2017. He is Chairman & Chief Executive Officer at Eli Lilly & Co. Ltd. and Eli Lilly Italia SpA. He serves as Chairman-Governors Board at James Whitcomb Riley Children's Foundation. He is an Independent Director at Adobe, Inc. since 2018. He is Director at Pharmaceutical Research & Manufacturers of America since 2022. He is Director at The Central Indiana Corporate Partnership. He is a Member of The Business Roundtable and The Business Council. Former roles include Director at European Federation of Pharmaceutical Industries & Assns, Director at Elanco Animal Health, Inc. from 2018 to 2019, Principal at HP, Inc., Principal at International Business Machines Corp., President at International Federation of Pharmaceutical Manufacturers, President at Lilly USA LLC from 2009 to 2012, President & General Manager at Lilly Industries Shanghai Ltd. in 2009, and General Manager at Eli Lilly Canada, Inc. from 2005 to 2008. Education includes an MBA from Indiana University in 1996 and an undergraduate degree from Purdue University in 1990.
William G. Kaelin
William G. Kaelin is the founder of Tango Therapeutics Sub, Inc. (founded in 2017), Cedilla Therapeutics, Inc. (founded in 2017), and Tango Therapeutics, Inc. (founded in 2017). Current jobs include Independent Director at Eli Lilly & Co. since 2012, Director at The Damon Runyon Cancer Research Foundation, Director at LifeMine Therapeutics, Inc. since 2021, Director at IconOVir Bio, Inc. since 2022, Independent Director at IQVIA Holdings, Inc. starting 2025, Trustee at Duke University, Professor at Dana-Farber Cancer Institute, Inc., Professor at The Brigham & Women's Hospital, Inc. since 2002, Member of the National Academy of Sciences, Member of the American Academy of Arts & Sciences, Member of the Association of American Physicians, Member of Dana-Farber, Member of the American Society of Clinical Investigation, Professor at Harvard Medical School since 2002, and Advisor at Casdin Capital. Former jobs include Chief Resident & House Officer at The Johns Hopkins Hospital, Inc., Member-Advisory Board at National Cancer Institute, Member of the National Academy of Medicine (United States), Member of the American College of Physicians, Inc., and Trustee of the American Association for Cancer Research. Education includes an undergraduate degree from Duke University conferred in 1982 and a doctorate from Duke University School of Medicine.
Juan Ricardo Luciano
Juan Ricardo Luciano is Chairman, President & Chief Executive Officer at Archer-Daniels-Midland Co. since 2016. He is Lead Independent Director at Eli Lilly & Co. since 2019. He serves as Director at Rush System for Health, The Business Council, Illinois Economic Development Corp., ADM Grain River System, Inc. since 2012, ADM Clinton BioProcessing, Inc. since 2012, and holds memberships at The Commercial Club of Chicago, The Business Roundtable, Dow Hydrocarbons & Resources LLC, Global Advisory Board since 2017, and The Economic Club of Chicago. Former roles include Director at ADM Alliance Nutrition, Inc., Non-Executive Director at Wilmar International Ltd. from 2012 to 2022, Director at The Economic Club of Chicago (Illinois), Director at Kellogg School of Management, President-Performance Division at The Dow Chemical Co. from 2010 to 2011, Trustee at Boys & Girls Clubs of America, Trustee at Rush University Medical Center, and Member of the US-China Business Council. Education includes undergraduate studies at Instituto Tecnológico de Buenos Aires.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
Jamere Jackson
Mr. Jamere Jackson, CPA, is a Chief Financial Officer at AutoZone, Inc. and an Independent Director at Eli Lilly & Co. He is on the Board of Directors at Eli Lilly & Co., Azaa Investments, Inc., Future 5 and Youth Villages, Inc. Mr. Jackson was previously employed as an Independent Director by Hibbett, Inc., a Chief Financial Officer & Executive Vice President by Hertz Global Holdings, Inc., a Chief Financial Officer & Executive Vice President by The Hertz Corp., a Chief Financial Officer by Nielsen NV, a Chief Financial Officer by VNU NV, a Chief Financial Officer by Nielsen Holdings Plc, a Chief Financial Officer by The Nielsen Company (US) LLC, a VP, Chief Financial Office-Drilling & Surface by GE Oil & Gas LLC, a Senior Executive-Finance by GE Aviation Systems LLC, a Principal by General Electric Co., a Principal by First Data Corp., a Principal by Procter & Gamble Co., a Principal by Total System Services LLC, a Treasurer by Unison Industries LLC, and a Principal by Yum! Brands, Inc. He received his undergraduate degree from the University of Notre Dame.
Gabrielle G. Greene-Sulzberger
Gabrielle G. Greene-Sulzberger founded Fontis Partners LP in 2009, where she worked as General Partner from 2009 to 2017. Ms. Greene-Sulzberger also currently works at Sesame Workshop, as Chairman, auxmoney GmbH, as Chairman, The Food Kitchen Ltd., as Chairman from 2019, and various other companies. Ms. Greene-Sulzberger also formerly worked at Johnson Products Co., Inc., as Chief Executive Officer from 2011 to 2013, Teneo Holdings LLC, as Chairman-ESG Practice, Teneo Consulting LLC, as Chairman-ESG Practice, and various other companies. Ms. Greene-Sulzberger received her Masters Business Admin degree in 1987 from Harvard Business School, graduate degree from Harvard Law School, and undergraduate degree from Woodrow Wilson School of Public & International Affairs.
Kimberly H. Johnson
Kimberly H. Johnson is currently an Independent Director at Eli Lilly & Co. since 2021. Ms. Johnson also serves as Director at Greater Washington Board of Trade, Share Our Strength, Inc., Calvert Impact Capital, Inc., After-School All-Stars, Planet Works, Inc., and Communities In Schools of The Nations Capital. Ms. Johnson is a Trustee at Princeton University. Formerly, Ms. Johnson was Chief Operating Officer & Executive Vice President at Federal National Mortgage Association from 2018 to 2022. Ms. Johnson was Chief Operating Officer at T. Rowe Price Group, Inc. from 2022 to 2025. Ms. Johnson was Director at Credit Suisse Group AG and Credit Suisse (USA) LLC. Ms. Johnson worked as an Equity Trader at D. E. Shaw & Co. LLC. Ms. Johnson completed undergraduate studies at Princeton University and earned an MBA from Columbia Business School.
Mary Lynne Hedley
Mary Lynne Hedley was the founder of Zycos, Inc., founded in 1996, where the title held was President & Chief Executive Officer from 1996 to 2004. Dr. Hedley is the founder of Tesaro, Inc., founded in 2010, holding the title of President & Director. Current jobs include Independent Director at Eli Lilly & Co. since 2022, Independent Director at Veeva Systems, Inc. since 2019, Director at Millendo Therapeutics US, Inc. since 2017, Director at Helsinn Holding SA since 2021, Director at Youville Place, Director at Women Innovating Together In Healthcare, Director at Youville Assisted Living Residences, Venture Partner at Third Rock Ventures LLC since 2023, Member of The American Association of Immunologists, Member of the American Association for the Advancement of Science, Member of the American Society of Clinical Oncology, Inc., and Member of The American Association of Cancer Research. Former jobs include Independent Director at Receptos LLC from 2014 to 2015, Independent Director at Genetix Biotherapeutics, Inc. from 2017 to 2019, Independent Director at Millendo Therapeutics, Inc. from 2017 to 2021, Director at Helsinn Healthcare SA from 2021 to 2023, Independent Non-Executive Director at Centessa Pharmaceuticals Plc from 2021 to 2026, Chief Scientific Officer & Executive VP at MGI PHARMA, Inc. from 2004 to 2008, Chief Scientific Officer & EVP-Operations at Abraxis BioScience, Inc. from 2009 to 2010, Executive Vice President at Eisai Corp. of North America from 2008 to 2009, and General Manager & Senior Vice President at MGI PHARMA Biologics, Inc. Education includes an undergraduate degree from Purdue University conferred in 1983 and a doctorate from The University of Texas Southwestern Medical Center conferred in 1988.
Jon R. Moeller
Jon R. Moeller is currently Chairman, President & Chief Executive Officer at Procter & Gamble Service GmbH; Executive Chairman at Procter & Gamble Co. starting in 2026; Chief Operating Officer, CFO & Vice Chairman at Procter & Gamble (Manufacturing) Ireland Ltd.; Director at MDVIP LLC (Florida), Natura Pet Products, Inc., The Consumer Goods Forum, Isle of Harris Distillers Ltd., Alliance To End Plastic Waste, The Business Roundtable, and Eli Lilly & Co. since 2024; Trustee at Commercial Club of Cincinnati; Vice President at Cincinnati Art Museum; and Member of The Conference Board Council of Financial Executives. Former roles include Independent Director at Monsanto Co. from 2011 to 2018 and Trustee at Visiting Nurse Association. Education includes an undergraduate degree earned in 1986 and an MBA earned in 1988, both from Cornell University.
Carolyn R. Bertozzi
Carolyn R. Bertozzi founded Redwood Bioscience, Inc. in 2008, TwoStep Therapeutics, Inc. in 2024, Palleon Pharmaceuticals, Inc. in 2015, Venn Biosciences Corp. in 2017, Lycia Therapeutics, Inc. in 2019, and Enable Biosciences, Inc. in 2016, where she worked as Chairman. Dr. Bertozzi also founded Firefly Bio, Inc. Dr. Bertozzi also currently works at Grace Science Foundation, as Director, OmniAb Operations, Inc., as Independent Director, OmniAb, Inc., as Independent Director from 2022, Stanford Chem-H, as Director from 2021, Xaira Therapeutics, Inc., as Director, Eli Lilly & Co., as Independent Director from 2025, Stanford University, as Professor, American Chemical Society, as Member, The Royal Society, as Member, Howard Hughes Medical Institute, Inc., as Professor, National Academy of Sciences, as Member, American Academy of Arts & Sciences, as Member, National Academy of Medicine (United States), as Member, American Society for Biochemistry & Molecular Biology, Inc., as Member, Accademia Nazionale dei Lincei, as Member, and National Academy of Inventors, as Member. Dr. Bertozzi also formerly worked at Eli Lilly & Co., as Independent Director from 2017 to 2021, Lawrence Berkeley National Laboratory, as Director-Molecular Foundry, The Broad Institute, Inc., as Director, Catalent, Inc., as Director, Molecular Foundry, as Director, Alnylam Pharmaceuticals, Inc., as Independent Director from 2023 to 2025, and the University of California, Berkeley, as Professor from 1996 to 2015. Dr. Bertozzi received her doctorate degree in 1993 from the University of California, Berkeley.
提供，免责声明：天汇财经、Factset及其他信息供应商努力确保所提供信息的准确性和可靠性，但对于其正确性或可靠性则不予担保，且对于因不正确或疏漏所造成的任何损失或损坏概不负责(无论是有关民事过失、合同或其他方面)。